204 related articles for article (PubMed ID: 19572156)
1. New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer.
Mustafi D; Peng B; Foxley S; Makinen MW; Karczmar GS; Zamora M; Ejnik J; Martin H
J Biol Inorg Chem; 2009 Nov; 14(8):1187-97. PubMed ID: 19572156
[TBL] [Abstract][Full Text] [Related]
2. Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
Amin SS; Cryer K; Zhang B; Dutta SK; Eaton SS; Anderson OP; Miller SM; Reul BA; Brichard SM; Crans DC
Inorg Chem; 2000 Feb; 39(3):406-16. PubMed ID: 11229556
[TBL] [Abstract][Full Text] [Related]
3. Structural origins of the insulin-mimetic activity of bis(acetylacetonato)oxovanadium(IV).
Makinen MW; Brady MJ
J Biol Chem; 2002 Apr; 277(14):12215-20. PubMed ID: 11815612
[TBL] [Abstract][Full Text] [Related]
4. The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor.
Ou H; Yan L; Mustafi D; Makinen MW; Brady MJ
J Biol Inorg Chem; 2005 Dec; 10(8):874-86. PubMed ID: 16235045
[TBL] [Abstract][Full Text] [Related]
5. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
Takino T; Yasui H; Yoshitake A; Hamajima Y; Matsushita R; Takada J; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):133-42. PubMed ID: 11293406
[TBL] [Abstract][Full Text] [Related]
6. X-ray fluorescence microscopy demonstrates preferential accumulation of a vanadium-based magnetic resonance imaging contrast agent in murine colonic tumors.
Mustafi D; Ward J; Dougherty U; Bissonnette M; Hart J; Vogt S; Karczmar GS
Mol Imaging; 2015; 14():. PubMed ID: 25813904
[TBL] [Abstract][Full Text] [Related]
7. Efficient Synthesis and HPLC-Based Characterization for Developing Vanadium-48-Labeled Vanadyl Acetylacetonate as a Novel Cancer Radiotracer for PET Imaging.
Broder BA; Bhuiyan M; Freifelder R; Rotsch DA; Chitneni SK; Makinen MW; Chen CT
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398551
[No Abstract] [Full Text] [Related]
8. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
9. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
D'Cruz OJ; Dong Y; Uckun FM
Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
[TBL] [Abstract][Full Text] [Related]
10. The vanadyl chelate bis(acetylacetonato)oxovanadium(IV) increases the fractional uptake of 2-(fluorine-18)-2-deoxy-D-glucose by cultured human breast carcinoma cells.
Makinen MW; Bamba R; Ikejimba L; Wietholt C; Chen CT; Conzen SD
Dalton Trans; 2013 Sep; 42(33):11862-7. PubMed ID: 23644715
[TBL] [Abstract][Full Text] [Related]
11. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
[TBL] [Abstract][Full Text] [Related]
12. Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds.
Crans DC
J Inorg Biochem; 2000 May; 80(1-2):123-31. PubMed ID: 10885472
[TBL] [Abstract][Full Text] [Related]
13. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
14. The Structural Basis of Action of Vanadyl (VO
Makinen MW; Salehitazangi M
Coord Chem Rev; 2014 Nov; 279():1-22. PubMed ID: 25237207
[TBL] [Abstract][Full Text] [Related]
15. Photocytotoxic oxovanadium(IV) complexes of ferrocenyl-terpyridine and acetylacetonate derivatives.
Balaji B; Balakrishnan B; Perumalla S; Karande AA; Chakravarty AR
Eur J Med Chem; 2015 Mar; 92():332-41. PubMed ID: 25576740
[TBL] [Abstract][Full Text] [Related]
16. Vanadium-induced formation of thiadiazole and thiazoline compounds. Mononuclear and dinuclear oxovanadium(v) complexes with open-chain and cyclized thiosemicarbazone ligands.
Rubcić M; Milić D; Horvat G; Dilović I; Galić N; Tomisić V; Cindrić M
Dalton Trans; 2009 Nov; (44):9914-23. PubMed ID: 19885541
[TBL] [Abstract][Full Text] [Related]
17. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
18. Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.
Liu JC; Yu Y; Wang G; Wang K; Yang XG
Metallomics; 2013 Jun; 5(7):813-20. PubMed ID: 23576171
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes.
Maurya MR; Agarwal S; Abid M; Azam A; Bader C; Ebel M; Rehder D
Dalton Trans; 2006 Feb; (7):937-47. PubMed ID: 16462954
[TBL] [Abstract][Full Text] [Related]
20. Structure and conformation of bis(acetylacetonato)oxovanadium(IV) and bis(maltolato)oxovanadium(IV) in solution determined by electron nuclear double resonance spectroscopy.
Mustafi D; Makinen MW
Inorg Chem; 2005 Aug; 44(16):5580-90. PubMed ID: 16060607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
